The Future of Ketamine and Temper Disorders In 2019, the FDA and European Commission accepted the use of an esketamine nasal spready under the manufacturer title Spravato to deal with despair. However, as of 2021, ketamine hasn't been authorised via the FDA to deal with depression or other mental wellbeing disorders, and thus, the medication is bei